A Label-free Microfluidic Chip for the Highly Selective Isolation of Single and Cluster CTCs from Breast Cancer Patients

Overview

Journal Transl Oncol

Specialty Oncology

Date 2020 Nov 28

PMID 33248414

Citations 12

Authors

Xiaofen Zhang

Xu Lu

Wanlei Gao

Yanmin Wang

Chunping Jia

Hui Cong

Affiliations

Soon will be listed here.

Abstract

Background: Circulating tumor cells (CTCs) existing in peripheral blood can be used to predict the prognosis and survival of cancer patients. The study was designed to detect circulating tumor cells and circulating tumor single cell genes by applying microfluidic chip technology. It was used to explore the clinical application value in breast cancer.

Methods: We have developed a size-based CTCs sorting microfluidic chip, which contains a hexagonal array and a micro-pipe channel array to isolate and confirm both single CTCs and CTCs clusters. The sorting performance of the as-fabricated chip was tested by analyzing the clinical samples collected from 129 breast cancer patients and 50 healthy persons.

Results: In this study, the chip can detect different immunophenotypes of CTCs in breast cancer patients. It was found that the new microfluidic device had high sensitivity (73.6%) and specificity (82.0%) in detecting CTCs. By detecting the blood samples of 129 breast cancer patients and 50 healthy blood donors, it was found that the number of CTCs was not associated with clinical factors such as age, gender, pathological type, and tumor size of breast cancer patients (P > 0.05), but was associated with TNM staging of breast cancer, with or without metastasis (P < 0.005). There was a statistically significant difference in the number of CTCs between luminal A (ER+/PR+/HER2-) and HER-2+ (ER-/PR-/HER2+) (P < 0.05). The best cut-off level distinguished by CTC between the breast cancer patients and the healthy persons was 3.5 cells/mL, with 0.845 for AUC-ROC, 0.790-0.901 for 95% CI, 73.6% for sensitivity, and 82% for specificity (P = 0.000). The combination of CTC, CEA, CA125 and CA153 can provide more effective breast cancer screening.

Conclusions: The CTCs analysis method presented here doesn't rely on the specific antibody, such as anti-EpCAM, which would avoid the missed inspection caused by antibody-relied methods and offer more comprehensive biological information for clinical breast cancer diagnosis and treatment.

Citing Articles

Tumor-on-chip platforms for breast cancer continuum concept modeling.

Neagu A, Whitham D, Bruno P, Versaci N, Biggers P, Darie C Front Bioeng Biotechnol. 2024; 12:1436393.

PMID: 39416279 PMC: 11480020. DOI: 10.3389/fbioe.2024.1436393.

Hypoxia stimulates CTC-platelet cluster formation to promote breast cancer metastasis.

Zhou W, Zhu C, Shen P, Wang J, Zhu G, Jia Y iScience. 2024; 27(5):109547.

PMID: 38660400 PMC: 11039329. DOI: 10.1016/j.isci.2024.109547.

Factors influencing the diagnostic and prognostic values of circulating tumor cells in breast cancer: a meta-analysis of 8,935 patients.

Zhao H, Wang L, Fang C, Li C, Zhang L Front Oncol. 2023; 13:1272788.

PMID: 38090481 PMC: 10711619. DOI: 10.3389/fonc.2023.1272788.

Clinical diagnostic biomarker "circulating tumor cells" in breast cancer - a meta-analysis.

Bai S, Lin S, Lin T, Wang Q, Cheng C, Lin J Front Oncol. 2023; 13:1137519.

PMID: 37397397 PMC: 10313226. DOI: 10.3389/fonc.2023.1137519.

Recent advances in micro-/nanostructure array integrated microfluidic devices for efficient separation of circulating tumor cells.

Kang H, Xiong Y, Ma L, Yang T, Xu X RSC Adv. 2022; 12(54):34892-34903.

PMID: 36540264 PMC: 9724214. DOI: 10.1039/d2ra06339e.

References

Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

Haber D, Velculescu V . Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov. 2014; 4(6):650-61. PMC: 4433544. DOI: 10.1158/2159-8290.CD-13-1014. View

Lee S, Lee J, Ahn M, Kim D, Sun J, Keam B . Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial. Ann Oncol. 2016; 28(2):292-297. DOI: 10.1093/annonc/mdw559. View

Tseng J, Yang C, Liang S, Liu R, Jiang J, Lin C . Dynamic changes in numbers and properties of circulating tumor cells and their potential applications. Cancers (Basel). 2014; 6(4):2369-86. PMC: 4276972. DOI: 10.3390/cancers6042369. View

Schiro P, Zhao M, Kuo J, Koehler K, Sabath D, Chiu D . Sensitive and high-throughput isolation of rare cells from peripheral blood with ensemble-decision aliquot ranking. Angew Chem Int Ed Engl. 2012; 51(19):4618-22. PMC: 3419755. DOI: 10.1002/anie.201108695. View

Gkountela S, Castro-Giner F, Szczerba B, Vetter M, Landin J, Scherrer R . Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding. Cell. 2019; 176(1-2):98-112.e14. PMC: 6363966. DOI: 10.1016/j.cell.2018.11.046. View

Harb W, Fan A, Tran T, Danila D, Keys D, Schwartz M . Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay. Transl Oncol. 2013; 6(5):528-38. PMC: 3799195. DOI: 10.1593/tlo.13367. View

Jiang Z, Cristofanilli M, Shao Z, Tong Z, Song E, Wang X . Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial. Ann Oncol. 2013; 24(11):2766-72. DOI: 10.1093/annonc/mdt246. View

10.

Gao W, Yuan H, Jing F, Wu S, Zhou H, Mao H . Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip. Oncotarget. 2017; 8(8):12917-12928. PMC: 5355066. DOI: 10.18632/oncotarget.14203. View

11.

Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F . A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer. 2011; 105(6):847-53. PMC: 3171010. DOI: 10.1038/bjc.2011.294. View

12.

Whitesides G . The origins and the future of microfluidics. Nature. 2006; 442(7101):368-73. DOI: 10.1038/nature05058. View

13.

Cheung K, Padmanaban V, Silvestri V, Schipper K, Cohen J, Fairchild A . Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci U S A. 2016; 113(7):E854-63. PMC: 4763783. DOI: 10.1073/pnas.1508541113. View

14.

Danova M, Torchio M, Mazzini G . Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications. Expert Rev Mol Diagn. 2011; 11(5):473-85. DOI: 10.1586/erm.11.33. View

15.

Johnson E, Anand R, Chiu D . Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen. Anal Chem. 2015; 87(18):9389-95. DOI: 10.1021/acs.analchem.5b02241. View

16.

Zhou J, Kulasinghe A, Bogseth A, OByrne K, Punyadeera C, Papautsky I . Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel. Microsyst Nanoeng. 2019; 5:8. PMC: 6387977. DOI: 10.1038/s41378-019-0045-6. View

17.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

18.

Murlidhar V, Zeinali M, Grabauskiene S, Ghannad-Rezaie M, Wicha M, Simeone D . A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells. Small. 2014; 10(23):4895-904. PMC: 4455044. DOI: 10.1002/smll.201400719. View

19.

Todenhofer T, Park E, Duffy S, Deng X, Jin C, Abdi H . Microfluidic enrichment of circulating tumor cells in patients with clinically localized prostate cancer. Urol Oncol. 2016; 34(11):483.e9-483.e16. DOI: 10.1016/j.urolonc.2016.06.004. View

20.

Fan X, Jia C, Yang J, Li G, Mao H, Jin Q . A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells. Biosens Bioelectron. 2015; 71:380-386. DOI: 10.1016/j.bios.2015.04.080. View